Familial hypercholesterolaemia (FH) is a common genetic cause of premature coronary
heart disease (CHD). Globally, one baby is born with FH every minute. If diagnosed and …

Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth
that markedly elevates plasma low-density lipoprotein (LDL) cholesterol and causes …

Background Although statins have been shown to reduce cardiovascular disease mortality,
less than half of US adults achieve their low-density lipoprotein cholesterol goal. In many …

Objective To verify the safety and effectiveness of traditional Chinese red yeast rice-extract
(RYR) for reduction of LDL cholesterol. Methods Systematic literature review and meta …

Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth
that causes marked elevation in plasma cholesterol and premature coronary heart disease …

Proprotein convertase subtilisin kexin 9 (PCSK-9)-targeting therapy has arisen as a new line
for the treatment of hyperlipidemia. Inclisiran is a double-stranded small RNA molecule that …

Familial hypercholesterolemia (FH) is a dominantly inherited disorder present from birth that
markedly elevates plasma low-density lipoprotein cholesterol and causes premature …

Purpose Intravitreal injection of VEGF inhibitors has become the standard of care for
different macular diseases within the last years resulting in improved visual outcomes …

Importance Many patients at high cardiovascular risk—women more commonly than men—
are not receiving statins. Anecdotally, it is common for patients to not accept statin therapy …

Background The 2013 American College of Cardiology/American Heart Association
Cholesterol Management Guideline identifies 4 statin-eligible groups:(1) known …